Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Microbiota alterations in COVID-19 patients appeared to be associated with secondary infections of the blood by gut bacteria: four cases of positive blood cultures of Staphylococcus species were identified.
The findings of a recent study suggest that DNA damage-inducing microbial metabolites such as indolimines play a role in the development of colorectal cancer.
The findings of a recent study suggest that a specific strain of Subdoligranulum can drive the production of autoantibodies in rheumatoid arthritis.
Scientists identified a bacterium, Bacteroides xylanisolvens, that reduced gut nicotine concentrations in mice exposed to nicotine as well as the severity of NAFLD.
A recent study provides evidence for the beneficial effects of GMD and the gut commensal bacterium P. merdae against obesity-related atherosclerosis.
The findings of a new research suggest that, in some people, microbial ethanol can contribute to the development of NAFLD.
The findings of a new research may help to develop improved diagnostic or treatment approaches for pancreatic cancer.
Researchers found that the microbiota of the recipient, rather than that of the donor, determines the microbial mix resulting from a fecal transplant.
New studies provide evidence that there may be fungi within tumors and could also help to diagnose certain types of cancer or predicting their course.
The findings of a new research could help to optimize fecal microbiota transplantation (FMT) protocols and identify the most suitable donors for transplantation.
